Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Shangguan M, Lu Y, Qi J, Han J, Tian Z, Xie Y, Hu F, Yuan H, Wu W.

J Biomater Appl. 2014 Feb;28(6):887-96. doi: 10.1177/0885328213485141. Epub 2013 Sep 5.

PMID:
24008629
2.

Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.

Yu Q, Hu X, Ma Y, Xie Y, Lu Y, Qi J, Xiang L, Li F, Wu W.

Drug Deliv. 2016 May;23(4):1469-75. doi: 10.3109/10717544.2016.1153744. Epub 2016 Mar 8.

PMID:
27187522
3.

Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.

Liu Y, Wang L, Zhao Y, He M, Zhang X, Niu M, Feng N.

Int J Pharm. 2014 Dec 10;476(1-2):169-77. doi: 10.1016/j.ijpharm.2014.09.052. Epub 2014 Oct 1.

PMID:
25280882
4.

Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.

Shangguan M, Qi J, Lu Y, Wu W.

Int J Pharm. 2015 Jul 15;489(1-2):195-202. doi: 10.1016/j.ijpharm.2015.05.005. Epub 2015 May 5.

PMID:
25956049
5.

Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway.

Chaudhary S, Garg T, Murthy RS, Rath G, Goyal AK.

Int J Pharm. 2015 May 15;485(1-2):108-21. doi: 10.1016/j.ijpharm.2015.02.070. Epub 2015 Feb 28.

PMID:
25735668
6.

Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.

Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P.

Int J Pharm. 2006 Aug 17;319(1-2):162-8. Epub 2006 Apr 1.

PMID:
16687221
7.

Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.

Cao X, Fu M, Wang L, Liu H, Deng W, Qu R, Su W, Wei Y, Xu X, Yu J.

Acta Biomater. 2012 Jul;8(6):2104-12. doi: 10.1016/j.actbio.2012.02.011. Epub 2012 Feb 17.

PMID:
22343518
8.

A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.

Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W.

Int J Pharm. 2014 Apr 25;465(1-2):90-6. doi: 10.1016/j.ijpharm.2014.02.013. Epub 2014 Feb 12.

PMID:
24530388
9.

[Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].

He J, Hou SX, Feng JF, Cai BQ.

Zhongguo Zhong Yao Za Zhi. 2005 Nov;30(21):1651-3. Chinese.

PMID:
16400939
10.

Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.

Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q.

Colloids Surf B Biointerfaces. 2010 Oct 15;80(2):213-8. doi: 10.1016/j.colsurfb.2010.06.008. Epub 2010 Jun 23.

PMID:
20621458
11.

Preparation and characterization of silybin-loaded nanostructured lipid carriers.

Jia LJ, Zhang DR, Li ZY, Feng FF, Wang YC, Dai WT, Duan CX, Zhang Q.

Drug Deliv. 2010 Jan;17(1):11-8. doi: 10.3109/10717540903431586. Epub 2009 Nov 26.

PMID:
19941406
12.

Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.

Wu W, Wang Y, Que L.

Eur J Pharm Biopharm. 2006 Jul;63(3):288-94. Epub 2006 Mar 9.

PMID:
16527467
13.

Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.

Ranpise NS, Korabu SS, Ghodake VN.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30.

PMID:
24445002
14.

Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement.

Tran TH, Ramasamy T, Truong DH, Choi HG, Yong CS, Kim JO.

AAPS PharmSciTech. 2014 Dec;15(6):1509-15. doi: 10.1208/s12249-014-0175-y. Epub 2014 Jul 18.

15.

Nanostructured lipid carriers as a delivery system of biochanin A.

Wang Q, Cheng H, Zhou K, Wang L, Dong S, Wang D, Chen W.

Drug Deliv. 2013 Nov;20(8):331-7. doi: 10.3109/10717544.2013.838716.

PMID:
24111887
16.

Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.

Khan S, Baboota S, Ali J, Narang RS, Narang JK.

Drug Dev Ind Pharm. 2016;42(2):209-20. doi: 10.3109/03639045.2015.1040414. Epub 2015 May 27.

PMID:
26016780
17.

Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

Dai W, Zhang D, Duan C, Jia L, Wang Y, Feng F, Zhang Q.

J Microencapsul. 2010 May;27(3):234-41. doi: 10.3109/02652040903079526.

PMID:
20113167
18.

Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.

Zhou X, Zhang X, Ye Y, Zhang T, Wang H, Ma Z, Wu B.

Int J Pharm. 2015 Feb 20;479(2):391-8. doi: 10.1016/j.ijpharm.2014.12.068. Epub 2014 Dec 30.

PMID:
25556104
19.

Montelukast-loaded nanostructured lipid carriers: part I oral bioavailability improvement.

Patil-Gadhe A, Pokharkar V.

Eur J Pharm Biopharm. 2014 Sep;88(1):160-8. doi: 10.1016/j.ejpb.2014.05.019. Epub 2014 May 27.

PMID:
24878424
20.

Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.

Borkar N, Xia D, Holm R, Gan Y, M├╝llertz A, Yang M, Mu H.

Eur J Pharm Sci. 2014 Jan 23;51:204-10. doi: 10.1016/j.ejps.2013.09.022. Epub 2013 Oct 14.

PMID:
24134899

Supplemental Content

Support Center